{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T10:53:31Z","timestamp":1792666411043,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T00:00:00Z","timestamp":1612224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004622","name":"KWF Kankerbestrijding","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004622","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.radonc.2021.01.024","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T23:10:19Z","timestamp":1612480219000},"page":"147-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"special_numbering":"C","title":["Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment"],"prefix":"10.1016","volume":"157","author":[{"given":"Lisa","family":"Van den Bosch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjen","family":"van der Schaaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Paul","family":"van der Laan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4317-9181","authenticated-orcid":false,"given":"Frank J.P.","family":"Hoebers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oda B.","family":"Wijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna G.M.","family":"van den Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel G.M.","family":"Moons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes B.","family":"Reitsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roel J.H.M.","family":"Steenbakkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewoud","family":"Schuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1083-372X","authenticated-orcid":false,"given":"Johannes A.","family":"Langendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2021.01.024_b0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2009.04.014","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients","volume":"92","author":"Pignon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0010","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJMoa0912217","article-title":"Human papillomavirus and survival of patients with oropharyngeal cancer","volume":"363","author":"Ang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2021.01.024_b0015","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2021.01.024_b0020","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S1470-2045(17)30458-8","article-title":"Role of radiotherapy fractionation in head and neck cancers (MARCH): an updated meta-analysis","volume":"18","author":"Lacas","year":"2017","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0025","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6&7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2021.01.024_b0030","doi-asserted-by":"crossref","first-page":"3770","DOI":"10.1200\/JCO.2007.14.6647","article-title":"Impact of late treatment-related toxicity on quality of life among patients with head and neck cancer treated with radiotherapy","volume":"26","author":"Langendijk","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0035","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1586\/14737140.7.7.1043","article-title":"Systemic and global toxicities of head and neck treatment","volume":"7","author":"Murphy","year":"2007","journal-title":"Expert Rev Anticancer Ther"},{"key":"10.1016\/j.radonc.2021.01.024_b0040","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.radonc.2014.03.024","article-title":"Estimating the demand for radiotherapy from the evidence: a review of changes from 2003 to 2012","volume":"112","author":"Barton","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0045","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.radonc.2015.07.042","article-title":"Patterns of long-term swallowing dysfunction after definitive radiotherapy or chemoradiation","volume":"117","author":"Christianen","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0050","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijrobp.2007.01.024","article-title":"Fatigue during head-and-neck radiotherapy: prospective study on 117 consecutive patients","volume":"68","author":"Jereczek-Fossa","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.024_b0055","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1002\/cncr.22302","article-title":"Radiation-induced xerostomia in patients with head and neck cancer: a literature review","volume":"107","author":"Dirix","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2021.01.024_b0060","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3857\/roj.2014.32.3.103","article-title":"Mechanisms of radiation-induced normal tissue toxicity and implications for future clinical trials","volume":"32","author":"Kim","year":"2014","journal-title":"Radiat Oncol J"},{"key":"10.1016\/j.radonc.2021.01.024_b0065","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.ijrobp.2008.01.012","article-title":"Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer","volume":"72","author":"Rosenthal","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.024_b0070","doi-asserted-by":"crossref","first-page":"i69","DOI":"10.1093\/jrr\/rrw047","article-title":"IMRT for head and neck cancer: Reducing xerostomia and dysphagia","volume":"57","author":"Wang","year":"2016","journal-title":"J Radiat Res"},{"key":"10.1016\/j.radonc.2021.01.024_b0075","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.clon.2012.05.006","article-title":"Intensity-modulated radiotherapy in the treatment of head and neck cancer","volume":"24","author":"O'Sullivan","year":"2012","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0080","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.radonc.2011.12.010","article-title":"Intensity-modulated radiotherapy in head and neck cancer: results of the prospective study GORTEC 2004\u201303","volume":"103","author":"Toledano","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.024_b0090","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","article-title":"Quantitative analyses of normal tissue effects in the clinic (QUANTEC): an introduction to the scientific issues","volume":"76","author":"Bentzen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.024_b0095","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.radonc.2014.08.020","article-title":"Direct use of multivariable normal tissue complication probability models in treatment plan optimisation for individualised head and neck cancer radiotherapy produces clinically acceptable treatment plans","volume":"112","author":"Kierkels","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0100","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.oraloncology.2018.08.018","article-title":"Revisiting the dose constraints for head and neck OARs in the current era of IMRT","volume":"86","author":"Brodin","year":"2018","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0105","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.radonc.2015.11.009","article-title":"Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: clinical validation according to the model-based approach","volume":"118","author":"Christianen","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0110","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.radonc.2015.07.041","article-title":"CT-based delineation of organs at risk in the head and neck region: DAHANCA, EORTC, GORTEC, HKNPCSG, NCIC CTG, NCRI, NRG Oncology and TROG consensus guidelines","volume":"117","author":"Brouwer","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0115","doi-asserted-by":"crossref","unstructured":"Altman DG, Vergouwe Y, Royston P, Moons KGM. Prognosis and prognostic research: Validating a prognostic model. Br Med J 2009;338:1432\u20135. https:\/\/doi.org\/10.1136\/bmj.b605.","DOI":"10.1136\/bmj.b605"},{"key":"10.1016\/j.radonc.2021.01.024_b0120","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M18-1377","article-title":"PROBAST: a tool to assess risk of bias and applicability of prediction model studies: explanation and elaboration","volume":"170","author":"Moons","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.radonc.2021.01.024_b0125","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.radonc.2020.02.013","article-title":"Generalizability assessment of head and neck cancer NTCP models based on the TRIPOD criteria","volume":"146","author":"Sharabiani","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0130","first-page":"1142","article-title":"Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD Statement","volume":"67","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.radonc.2021.01.024_b0135","doi-asserted-by":"crossref","first-page":"W1","DOI":"10.7326\/M14-0698","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): explanation and elaboration","volume":"162","author":"Moons","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.radonc.2021.01.024_b0140","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.radonc.2011.08.009","article-title":"Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study","volume":"105","author":"Christianen","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0145","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.radonc.2012.03.004","article-title":"NTCP models for patient-rated xerostomia and sticky saliva after treatment with intensity modulated radiotherapy for head and neck cancer: the role of dosimetric and clinical factors","volume":"105","author":"Beetz","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0150","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.radonc.2020.04.012","article-title":"Key challenges in normal tissue complication probability model development and validation: towards a comprehensive strategy","volume":"148","author":"Van den Bosch","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0155","series-title":"Multiple imputation for nonresponse in surveys","author":"Rubin","year":"1987"},{"key":"10.1016\/j.radonc.2021.01.024_b0160","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S0895-4356(01)00341-9","article-title":"Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis","volume":"54","author":"Steyerberg","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.radonc.2021.01.024_b0165","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1002\/sim.7179","article-title":"A closed testing procedure to select an appropriate method for updating prediction models","volume":"36","author":"Vergouwe","year":"2017","journal-title":"Stat Med"},{"key":"10.1016\/j.radonc.2021.01.024_b0170","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.radonc.2013.05.007","article-title":"Selection of patients for radiotherapy with protons aiming at reduction of side effects: the model-based approach","volume":"107","author":"Langendijk","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0175","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ijrobp.2015.10.004","article-title":"The quest for evidence for proton therapy: model-based approach and precision medicine","volume":"95","author":"Widder","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.024_b0180","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","article-title":"PROBAST: a tool to assess the risk of bias and applicability of prediction model studies","volume":"170","author":"Wolff","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.radonc.2021.01.024_b0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.clon.2016.12.001","article-title":"Normal Tissue Complication Probability (NTCP) modelling of severe acute mucositis using a novel oral mucosal surface organ at risk","volume":"29","author":"Dean","year":"2017","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0190","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.radonc.2016.05.015","article-title":"Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy","volume":"120","author":"Dean","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0195","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0360-3016(01)01512-7","article-title":"Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer","volume":"50","author":"Eisbruch","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.024_b0200","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.ijrobp.2011.09.004","article-title":"Reducing xerostomia after chemo-IMRT for head-and-neck cancer: Beyond sparing the parotid glands","volume":"83","author":"Little","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.024_b0205","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.radonc.2017.08.002","article-title":"Sparing all salivary glands with IMRT for head and neck cancer: Longitudinal study of patient-reported xerostomia and head-and-neck quality of life","volume":"126","author":"Hawkins","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0210","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ijrobp.2016.05.011","article-title":"Predictors of dysgeusia in patients with oropharyngeal cancer treated with chemotherapy and intensity modulated radiation therapy","volume":"96","author":"Sapir","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.024_b0215","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1080\/09553002.2018.1440092","article-title":"Mechanisms of inflammatory responses to radiation and normal tissues toxicity: clinical implications","volume":"94","author":"Najafi","year":"2018","journal-title":"Int J Radiat Biol"},{"key":"10.1016\/j.radonc.2021.01.024_b0220","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.radonc.2016.08.022","article-title":"Toward a model-based patient selection strategy for proton therapy: external validation of photon-derived normal tissue complication probability models in a head and neck proton therapy cohort","volume":"121","author":"Blanchard","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2021.01.024_b0225","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1002\/sim.5732","article-title":"A framework for developing, implementing, and evaluating clinical prediction models in an individual participant data meta-analysis","volume":"32","author":"Debray","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/j.radonc.2021.01.024_b0230","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-07586-x","article-title":"Voxel-based analysis unveils regional dose differences associated with radiation-induced morbidity in head and neck cancer patients","volume":"7","author":"Monti","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.radonc.2021.01.024_b0235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0360-3016(91)90173-2","article-title":"Histogram reduction method for calculating complication probabilities for three-dimensional treatment planning evaluations","volume":"21","author":"Kutcher","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2021.01.024_b0240","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.radonc.2013.07.007","article-title":"Rapid Learning health care in oncology \u2019 \u2013 an approach towards decision support systems enabling customised radiotherapy","volume":"109","author":"Lambin","year":"2013","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021060217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814021060217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:15:16Z","timestamp":1759122916000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814021060217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":48,"alternative-id":["S0167814021060217"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2021.01.024","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739500115.793590385","asserted-by":"object"}]},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive toxicity risk profiling in radiation therapy for head and neck cancer: A new concept for individually optimised treatment","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2021.01.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}